-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Adaptive Biotechnologies Corp quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2017 to 2023.
- Adaptive Biotechnologies Corp Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$38.4M, a 35.2% increase year-over-year.
- Adaptive Biotechnologies Corp annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$156M, a 15% increase from 2022.
- Adaptive Biotechnologies Corp annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$184M, a 4.56% increase from 2021.
- Adaptive Biotechnologies Corp annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$193M, a 28.8% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)